SEC Form 4 · accession 0001179022-16-000096
GALECTIN THERAPEUTICS INC · GALT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
James C Czirr
Director
Period of report
Apr 19, 2016
Accepted (ET)
Apr 21, 2016 · 5:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001133416
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F3 | Apr 19, 2016 | S | 33,100 | $1.7005 | D | 3,271,909 | I | By 10X Fund, L.P. |
| Common StockF2,F3 | Apr 20, 2016 | S | 11,212 | $1.5922 | D | 3,260,697 | I | By 10X Fund, L.P. |
| Common Stock | holding | — | — | — | 886,630 | D | ||
| Common Stock | holding | — | — | — | 179,232 | I | By Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Reflects weighted average price. Range of prices were between $1.69 and $1.715. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
- F2Reflects weighted average price. Range of prices were between $1.55 and $1.62. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
- F3The transaction was consummated by 10X Fund, L.P., a Delaware limited partnership, and not by the Reporting Person. The Reporting Person is a managing member of 10X Capital Management, LLC, a Florida limited liability company acting as the general partner of 10X Fund, L.P., and as such, may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. Mr. Czirr disclaims beneficial ownership of the reported securities except to the extent of his after fund payout pecuniary interest therein.